ArticleBreast cancer research and treatment2024

Phosphoenolpyruvate carboxykinase-2 (PCK2) is a therapeutic target in triple-negative breast cancer.

Vignesh Gunasekharan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.